News
STVN
26.81
-5.03%
-1.42
Weekly Report: what happened at STVN last week (0422-0426)?
Weekly Report · 4d ago
Weekly Report: what happened at STVN last week (0415-0419)?
Weekly Report · 04/22 09:27
Weekly Report: what happened at STVN last week (0408-0412)?
Weekly Report · 04/15 09:25
Weekly Report: what happened at STVN last week (0401-0405)?
Weekly Report · 04/08 09:26
Stevanato names Ugo Gay as its new COO
Stevanato names Ugo Gay as its new COO. Gay has nearly three decades of experience in industry, business management, supply chain and operations. Stevanato Group S.p.A. (STVN) The company has appointed Gay as the new CEO.
Seeking Alpha · 04/04 12:24
Stevanato Group Appoints Ugo Gay As Chief Operations Officer
Strengthening corporate leadership aims to drive operational efficiencies and standardization of global processes. Stevanato Group S.p.A. Announced the appointment of Ugo Gay as its new Chief Operations Officer (COO) Ugo gay brings nearly three decades of experience in industry, business management, supply chain, and operations to the company. The company is a leading provider of drug containment, drug delivery, and diagnostic solutions.
Benzinga · 04/04 12:14
Weekly Report: what happened at STVN last week (0325-0329)?
Weekly Report · 04/01 09:26
International Companies Drive Diabesity Innovation
Diabetes and obesity markets are large and growing, with an estimated total long-term addressable market of $100 billion in the US alone. Denmark's Novo Nordisk and US-based Eli Lilly are leading pharmaceutical companies in the development of GLP-1-based treatments for diabetes and obesity. There is potential for global market expansion as millions of people are obese or at risk for diabetes but not receiving treatment.
Seeking Alpha · 03/29 13:59
Stevanato Group Completes Major Share Offering
Stevanato Group S.p.A., a major player in pharmaceutical and life sciences solutions, has successfully closed an upsized public offering. The company raised $379.7 million through the sale of 14,605,000 ordinary shares. STVN aims to utilize the proceeds for general corporate purposes.
TipRanks · 03/27 10:59
Stevanato Group Announces Major Share Offering
TipRanks · 03/27 10:18
Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares
Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. Stevanato Group announced the closing of its previously announced public offering of 14,605,000 of its ordinary shares at a public offering price of $26.00 per share. The total gross proceeds from the Company Offering were $379.7 million.
Barchart · 03/26 15:10
Stevanato Group Launches Major Share Offering
TipRanks · 03/25 21:28
Stevanato Group S P A: Prospectus [Rule 424(b)(5)]
Press release · 03/25 20:16
Stevanato Group Price Target Maintained With a $38.00/Share by Stephens & Co.
Dow Jones · 03/25 14:51
Stephens & Co. Reiterates Overweight on Stevanato Gr, Maintains $38 Price Target
Benzinga · 03/25 14:38
Weekly Report: what happened at STVN last week (0318-0322)?
Weekly Report · 03/25 09:27
BUZZ-U.S. STOCKS ON THE MOVE-Reddit, Alphabet, Tesla
The blue-chip Dow and the benchmark S&P 500 eased on Friday, but are still on track for strong weekly gains. Investors cheered the Federal Reserve's rate-easing stance. Reddit, Alphabet and Tesla were among the biggest losers on Wall Street. The Dow Jones Industrial Average was down 0.46% and the Nasdaq Composite was up.
Reuters · 03/22 17:59
BUZZ-U.S. STOCKS ON THE MOVE-Hookipa Pharma, Foot Locker, Baidu
S&P 500 and the Nasdaq were set to open lower on Friday after strong gains in the previous session. Investors cheered the Federal Reserve sticking to its rate-easing stance. Hookipa Pharma, Foot Locker, Baidu are among the top stocks on the U.S. Market.
Reuters · 03/22 13:14
Health Care Sector Update for 03/22/2024: ETON, OTLK, STVN, XLV, IBB
NASDAQ · 03/22 13:08
BUZZ-Stevanato slips as co, founding family sell shares in upsized equity offering
Stevanato Group S.p.N down 2.5% at $27.61 premarket after equity offering priced. Italian medical equipment supplier Stevanato Group sells 12.7 mln shares at $26 for $330 mln total raise. Co, founding family sell shares in upsized equity offering. Offering size boosted from $300 million.
Reuters · 03/22 12:38
More
Webull provides a variety of real-time STVN stock news. You can receive the latest news about Stevanato Group S P A through multiple platforms. This information may help you make smarter investment decisions.
About STVN
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.